A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

Using FoundationOne Liquid, a novel liquid biopsy test providing targeted gene and microsatellite instability-high results, researchers sought to examine whether specific biomarkers contribute to TNBC ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its ...

Chicago, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Circana, LLC today announced the launch of Liquid Testing™, an AI-powered, self-serve tool that gives consumer packaged goods and general merchandise ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...

A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...

PALO ALTO, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s ...

insights from industryErik GublerProduct ManagerMettler-Toledo GmbH In this interview, AZoM speaks to Erik Gubler, Product Manager at Mettler-Toledo GmbH, about e-liquid testing; how to do it, why it ...